Building the country's pharmaceutical sovereignty through innovation and technology
Pharmasyntez group
Every medicine comes with a responsibility to people.
International Standards
Manufacturing in accordance with GMP requirements. Rigorous quality control at every stage — from the active substance to the finished dosage form
Transparency
We engage openly with government authorities, partners and international regulators to demonstrate compliance with established requirements
.webp&w=3840&q=90)
Safety
We continuously monitor the safety of medicines throughout their life cycle
International Standards
Manufacturing in accordance with GMP requirements. Rigorous quality control at every stage — from the active substance to the finished dosage form
Safety
We continuously monitor the safety of medicines throughout their life cycle
Transparency
We engage openly with government authorities, partners and international regulators to demonstrate compliance with established requirements
Pharmasyntez — an integrated system of pharmaceutical solutions
Company portfolio
Focusing on diseases of major public health importance
Learn more.webp&w=1920&q=90)
We develop and manufacture modern medicines for the treatment of HIV infection and chronic viral hepatitis B and C. The company's medicines are included in more than 80% of HIV treatment regimens in Russia, including fixed combinations of several active substances in a single tablet. The portfolio also covers modern treatment regimens for viral hepatitis
We manufacture a broad range of anti-tuberculosis medicines. One in three packs of anti-tuberculosis medicines in Russia is manufactured at the company's facilities
We develop and manufacture modern biotechnology medicines for immunotherapy and targeted cancer treatment. Building our in-house scientific capabilities, introducing advanced technologies and maintaining a full production cycle enable us to create effective medicines and expand patients' access to modern anticancer treatment
We provide comprehensive supplies of modern medicines, consumables and medical equipment for all types of dialysis to nephrology patients, including those receiving renal replacement therapy
We develop and manufacture medicines for endocrine disorders, including adrenal and thyroid disorders, neuroendocrine tumours and diabetes mellitus. We provide patients with modern insulins, glucose-lowering medicines and incretin-based therapies. We are expanding our portfolio by localising the production of innovative hormonal medicines at our own manufacturing sites
We develop and manufacture modern medicines for men's and women's health. The portfolio includes medicines for urological disorders in men and hormonal medicines to support women's reproductive health at different stages of life
We develop medicines to treat rare diseases, including Wilson disease, atypical haemolytic uraemic syndrome, paroxysmal nocturnal haemoglobinuria, immune thrombocytopenia and pulmonary arterial hypertension
We manufacture a full range of anti-tuberculosis medicines. We manufacture one in three packs of tuberculosis medicines in Russia
Group companies
Developing manufacturing infrastructure across Russia
_converted.webp&w=1920&q=90)
_converted.webp&w=1920&q=90)
_converted.webp&w=1920&q=90)
.webp&w=1920&q=90)
_converted.webp&w=1920&q=90)
%2520(1)%25202.webp&w=1920&q=90)
.webp&w=1920&q=90)
Innovation
Building a sustainable system for advanced development
- 001
In-house research centres
We adapt advanced technologies and participate in international research projects
- 002
Sharing expertise and technology
We support the development of manufacturing sites and help introduce modern pharmaceutical technologies
- 003
Investment in innovative research
Annual investment in innovative projects exceeds 500 million roubles.
Careers
Work that makes a real difference to millions
Support for professional growth, opportunities to fulfil your potential and a comfortable working environment provide a foundation for confident progress at every stage of your career.
Joining forces to strengthen pharmaceuticals worldwide
Research collaboration
We undertake joint research projects and adapt medicines to the needs of local markets
News
